TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
WAT

Waters Corporation

Healthcare · Diagnostics & Research

423.90$ +0.5% vs. previous close Closing price · As of: Sep 21, 2026

Statements

Ratios

Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.

Tick rows to compare them in a chart (up to 4)

Ratios WAT
Line item 1996 1997 1998 1999 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Valuation
35.1 28.7 78.6 46.6 20.0 24.8 25.7 21.7 23.0 30.2 11.4 18.6 19.1 15.8 16.8 19.2 22.2 23.8 21.0 766.7 24.7 26.9 29.6 33.4 29.2 30.4 34.6 35.3
2.3 2.4 4.2 5.0 14.4 6.2 3.3 4.4 5.2 3.8 4.0 5.5 2.3 4.0 4.4 3.7 4.2 4.5 4.8 5.5 5.0 6.7 6.1 6.6 6.5 8.3 7.0 6.6 7.5 7.2
14.0 15.8 16.4 12.0 25.3 9.2 4.4 7.2 8.5 15.5 14.1 13.8 5.6 7.1 6.8 5.6 5.3 4.9 5.1 5.4 4.8 7.0 9.3 66.5 62.9 41.0 17.0 12.1 8.9
2.3 2.4 4.2 5.0 14.3 5.9 3.0 4.3 5.1 4.1 4.3 5.7 2.4 4.2 4.7 4.0 4.6 5.0 5.3 6.1 5.7 7.3 6.2 7.8 7.0 8.7 7.3 7.3 7.9 7.6
10.4 19.0 15.8 17.1 47.2 27.8 11.2 16.2 17.4 14.4 15.7 20.9 8.0 13.8 15.1 12.5 14.5 15.9 17.2 18.5 16.5 21.1 17.9 22.7 21.1 24.6 21.5 26.3 22.6 23.7
20.0 28.4 27.4 81.4 36.4 16.3 34.6 29.8 17.7 24.1 26.1 10.6 18.5 18.5 16.6 22.5 23.6 23.7 24.5 20.5 25.6 30.7 33.2 25.0 39.9 48.3 44.1 35.7 42.0
5.0% -7.5% 3.5% 3.7% 1.2% 2.8% 6.1% 2.9% 3.4% 5.6% 4.2% 3.8% 9.5% 5.4% 5.4% 6.0% 4.4% 4.2% 4.2% 4.1% 4.9% 3.9% 3.3% 3.0% 4.0% 2.5% 2.1% 2.3% 2.8% 2.4%
Margins
65.8% 65.9% 65.5% 66.6% 66.6% 63.8% 58.0% 58.5% 58.8% 58.7% 58.1% 57.2% 58.0% 60.3% 60.2% 60.5% 60.0% 58.9% 58.5% 58.7% 58.9% 59.0% 59.0% 58.0% 57.4% 58.5% 58.0% 59.6% 59.4% 57.8%
18.0% 8.1% 22.0% 25.1% 26.5% 17.4% 22.1% 22.9% 25.8% 24.4% 23.4% 23.7% 24.7% 26.3% 27.4% 28.6% 27.7% 27.2% 26.0% 27.8% 28.8% 28.7% 30.6% 29.4% 27.3% 29.5% 29.4% 27.7% 27.9% 28.2%
-0.6% -1.8% 12.0% 17.4% 18.3% 13.3% 16.6% 17.8% 20.3% 17.4% 17.4% 18.2% 20.5% 21.6% 23.2% 23.4% 25.0% 23.6% 21.7% 23.0% 24.1% 0.9% 24.5% 24.6% 22.1% 24.9% 23.8% 21.7% 21.6% 20.3%
11.7% -17.8% 14.9% 18.2% 17.6% 17.1% 20.4% 12.8% 17.5% 21.3% 16.6% 21.1% 22.2% 21.6% 24.0% 22.3% 18.7% 19.2% 20.4% 22.4% 24.6% 26.3% 19.7% 19.9% 26.1% 20.8% 14.4% 15.0% 20.9% 17.1%
Returns
-3.7% -11.8% 46.7% 41.9% 32.2% 19.7% 22.2% 28.9% 33.0% 71.2% 61.3% 45.7% 48.8% 38.1% 35.7% 35.3% 31.4% 25.5% 22.8% 22.8% 22.7% 0.9% 37.9% 224.7% 188.5% 140.3% 55.8% 34.9% 25.1%
-0.7% -1.5% 12.9% 20.9% 21.0% 12.9% 14.6% 15.1% 15.3% 14.1% 13.7% 14.3% 19.9% 16.9% 16.4% 15.9% 14.6% 12.6% 11.1% 11.0% 11.2% 0.4% 15.9% 23.2% 18.4% 22.4% 21.6% 13.9% 14.0% 12.7%
Balance Sheet & Debt
1.1 4.3 -1.2 10 -71 -226 -256 -110 -82 333 389 287 108 291 458 607 697 883 1,043 1,181 1,322 1,355 352 2,926 1,098 1,041 1,171 1,988 1,328 1,311
0.0 0.1 0.0 0.1 -0.3 -1.2 -1.1 -0.4 -0.3 1.0 1.1 0.7 0.2 0.6 0.9 1.0 1.2 1.5 1.7 1.8 1.8 1.7 0.4 3.5 1.4 1.1 1.2 2.4 1.3 1.3
17.8% 12.8% 27.6% 50.0% 65.3% 65.6% 65.8% 52.2% 46.5% 19.8% 22.4% 31.2% 40.7% 44.5% 45.9% 45.0% 46.3% 49.3% 48.8% 48.3% 49.4% 41.8% 42.0% -8.5% 8.2% 11.9% 15.4% 24.9% 40.2% 50.5%
0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.4 0.7 2.9 2.5 1.5 0.8 0.7 0.7 0.8 0.8 0.8 0.8 0.8 0.8 0.9 0.7 6.6 4.2 3.3 2.1 0.9 0.7
Per Share
-0.02 -0.07 0.62 0.92 1.06 0.83 1.09 1.34 1.82 1.74 2.13 2.62 3.21 3.34 4.06 4.69 5.19 5.20 5.07 5.65 6.41 0.25 7.65 8.69 8.36 11.17 11.73 10.84 10.71 10.76
3.26 4.00 5.17 5.31 5.81 6.25 6.56 7.51 8.97 9.99 12.28 14.37 15.66 15.47 17.47 20.05 20.72 22.00 23.36 24.58 26.62 28.65 31.18 35.30 37.90 44.91 49.26 49.88 49.68 53.01
0.54 0.60 1.33 2.20 3.30 4.23 4.90 4.63 5.51 2.45 3.48 5.72 6.57 8.76 11.36 13.29 16.49 20.37 22.25 24.78 28.27 27.71 20.19 -3.17 3.72 5.93 8.36 19.41 30.70 42.90
0.38 -0.71 0.77 0.97 1.03 1.07 1.34 0.96 1.57 2.13 2.04 3.03 3.47 3.35 4.20 4.46 3.87 4.23 4.76 5.50 6.56 7.53 6.14 7.03 9.90 9.33 7.10 7.46 10.41 9.04

Data as of: September 21, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?